Day One Biopharmaceuticals
DAWN
DAWN
130 hedge funds and large institutions have $952M invested in Day One Biopharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 56 increasing their positions, 35 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
130
Holders Change
-9
Holders Change %
-6.47%
% of All Funds
2.07%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
13
Increased
56
Reduced
35
Closed
21
Calls
$813K
Puts
$775K
Net Calls
+$38K
Net Calls Change
-$391K
Top Buyers
1 |
BlackRock
New York
|
$57.5M |
2 |
PHS
PFM Health Sciences
San Francisco,
California
|
$27.3M |
3 |
Point72 Asset Management
Stamford,
Connecticut
|
$6.68M |
4 |
Geode Capital Management
Boston,
Massachusetts
|
$15.9M |
5 |
B
Braidwell
Stamford,
Connecticut
|
$45.6M |